OWC Pharmaceutical Research (OWC Pharmaceutical Research) EV-to-EBIT : 0.00 (As of May. 31, 2024)

OWC Pharmaceutical Research EV-to-EBIT Chart

OWC Pharmaceutical Research Annual Data
	Trend	Dec08	Dec11	Dec12	Dec13	Dec14	Dec15	Dec16	Dec17	Dec18
EV-to-EBIT		Get a 7-Day Free Trial				-2.65	-1.26	-11.40	-14.39	-1.13

OWC Pharmaceutical Research Quarterly Data
	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19
EV-to-EBIT	Get a 7-Day Free Trial															-5.12	-1.13	-0.25	-0.26	-0.11

Competitive Comparison of OWC Pharmaceutical Research's EV-to-EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, OWC Pharmaceutical Research's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

OWC Pharmaceutical Research's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, OWC Pharmaceutical Research's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where OWC Pharmaceutical Research's EV-to-EBIT falls into.

OWC Pharmaceutical Research EV-to-EBIT Calculation

OWC Pharmaceutical Research's EV-to-EBIT for today is calculated as:

OWC Pharmaceutical Research's current Enterprise Value is $0.00 Mil.
OWC Pharmaceutical Research's EBIT for the trailing twelve months (TTM) ended in Sep. 2019 adds up the quarterly data reported by the company within the most recent 12 months, which was $-9.73 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OWC Pharmaceutical Research  (OTCPK:OWCP) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

OWC Pharmaceutical Research's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2019 is calculated as:

OWC Pharmaceutical Research's Enterprise Value for the quarter that ended in Sep. 2019 was $1.03 Mil.
OWC Pharmaceutical Research's EBIT for the trailing twelve months (TTM) ended in Sep. 2019 adds up the quarterly data reported by the company within the most recent 12 months, which was $-9.73 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OWC Pharmaceutical Research EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of OWC Pharmaceutical Research's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

OWC Pharmaceutical Research (OWC Pharmaceutical Research) Business Description